Nonprofit hospitals must finally prove they earn their tax breaks

What it does

This bill requires nonprofit hospitals that receive tax-exempt status to disclose far more detailed financial information on their annual IRS filings, including how much they spend on community health needs, financial assistance to patients, advertising, and specific service lines like oncology or cardiology. Larger hospitals (over 100 beds) and high-revenue hospitals (over $100 million in net patient revenue) face additional reporting requirements, including disclosure of profits from the federal 340B drug discount program. The bill benefits patients and the public by making it easier to hold nonprofit hospitals accountable for the community benefits they are supposed to provide in exchange for their tax-exempt status.

Why we flagged it

The bill's core function is forcing nonprofit hospitals to publicly justify their tax-exempt status through detailed financial disclosures, making it fundamentally an accountability and transparency measure targeting a sector that receives billions in annual tax benefits.

What the text implies

• The 340B drug discount program reporting requirements could expose how much profit large hospital systems extract from the program — hospitals buy drugs at steep discounts but often bill insurers and patients at full price, and this disclosure could fuel legislative efforts to reform or restrict 340B participation.
• The GAO study mandated in Section 3 explicitly estimates how much tax revenue the federal government foregoes by exempting the 25 largest nonprofit hospital systems — this is a clear legislative signal that future legislation could threaten tax-exempt status for hospitals deemed insufficiently charitable.

The full analysis lists 5 implications of this text.

Who stands to gain

healthcare transparency and compliance technology vendors; healthcare consulting firms; health data analytics companies